سعر باريكتوماب Barictomap‏ 4 مجم 30 قرص 2026

Barictomap 4 mg film-coated tablets, pack of 30 (Apex Pharma): baricitinib, an oral Janus kinase (JAK) inhibitor.

• None stated in the US prescribing information.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Boxed warning: serious infections (bacterial, fungal, viral, opportunistic, including tuberculosis) leading to hospitalization or death; higher all-cause mortality, malignancy (including lymphoma), major adverse cardiovascular events and thrombosis observed with JAK inhibitors. Test for latent TB before and during therapy (except COVID-19); do not give with active TB.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Other precautions: hypersensitivity reactions, gastrointestinal perforations, hypoglycaemia in diabetic patients, laboratory abnormalities (lymphocytes, neutrophils, haemoglobin, liver enzymes, lipids).International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Strong OAT3 inhibitors (e.g. probenecid)Increase baricitinib exposure; reduce the baricitinib dose by half.DailyMed (U.S. National Library of Medicine)
• Other JAK inhibitors, biologic DMARDs, potent immunosuppressants (azathioprine, cyclosporine)Combination not studied/not recommended.DailyMed (U.S. National Library of Medicine)

• Based on animal reproduction studies, baricitinib may cause fetal harm; a pregnancy exposure registry exists.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Advise not to breastfeed during treatment.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Baricitinib: Selective, reversible inhibitor of JAK1 and JAK2, which transduce signals for cytokines and growth factors involved in haematopoiesis, inflammation and immune function.